Home OMEICOS Receives BMBF Research Grant To Advance Its Novel Approach To Treat Atrial Fibrillation
 

Keywords :   


OMEICOS Receives BMBF Research Grant To Advance Its Novel Approach To Treat Atrial Fibrillation

2015-11-03 05:07:41| drugdiscoveryonline News Articles

OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation, recently announced the approval of an approximately €1.7Mgrant by the German Ministry of Education and Research (BMBF)

Tags: research approach advance grant

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Hurricane Beryl Graphics
03.07Atlantic Tropical Weather Outlook
03.07Hurricane Beryl Public Advisory Number 17A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07How Microsoft and Nvidia bet correctly to leapfrog Apple
03.07Acreage and stocks estimates push corn prices lower
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
More »